Comparative Study
Journal Article
Add like
Add dislike
Add to saved papers

Predicting renal replacement therapy and mortality in CKD.

BACKGROUND: Prognostic risk scores can help clinicians intervene on higher risk patients and counsel them. Our objective is to identify characteristics that predict the rate of progression to renal replacement therapy (RRT) and evaluate how those characteristics predict mortality and a composite end point (RRT and mortality).

STUDY DESIGN: Retrospective cohort study.

SETTING & PARTICIPANTS: We conducted the study at Kaiser Permanente Northwest, a health maintenance organization. We followed up members with an estimated glomerular filtration rate (eGFR) that indicated chronic kidney disease (2 eGFRs < 60 mL/min/1.73 m(2) [<1.0 mL/s/1.73 m(2)] at least 90 days apart).

PREDICTORS: We measured baseline clinical characteristics between January 1997 and June 2000 by using electronic medical records and patients' histories of hospitalization.

OUTCOMES & MEASUREMENTS: We calculated adjusted hazard ratios and concordance statistics for progression to RRT, mortality, and the composite by using Cox regression.

RESULTS: Patients (n = 6,541) were followed up for up to 5 years. We observed 1.6 progressions to RRT/100 person-years and 11.4 deaths/100 person-years. The 6 characteristics of age, sex, eGFR, diabetes, hypertension, and anemia predicted RRT effectively (c statistic, 0.91). However, hypertension and age predicted in the opposite direction for mortality and its composite end point. The c statistic decreased: mortality (0.70), mortality and RRT (0.71).

LIMITATIONS: Characteristics were measured without a protocol; extensive missing data prevented the evaluation of known risk factors (eg, proteinuria).

CONCLUSIONS: Predicting RRT effectively requires a separate risk score. Predicting the composite end point would favor characteristics that predict mortality because it is 7 times as common as RRT.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app